Similarly, SIRT4 expression was not associated with TNM stages in our cohort of 30 HCC patients (p = 0.139 for SIRT4 expression in patients with HCC stage I/II vs. stage III). This evidence concerns the gene SIRT4 and hepatocellular carcinoma.